Participated · Series D · Sep 2025

Founded in 2020, Thyme Care builds an integrated oncology infrastructure that aligns payers, providers, employers, and patients around value-based care. Its technology stack combines AI-driven orchestration, advanced data analytics, and a virtual/hybrid care team of doctors, nurses, social workers, and care partners to guide patients through every stage of the cancer journey. The company now partners with more than 1,000 oncologists and reaches 8 million covered lives, managing over $5 billion in oncology spend. Outcomes include 90% of members feeling more supported, 72% proactively submitting ePRO updates, 40% fewer ER visits, and 19% fewer hospital admissions among engaged members. One partner practice saved nearly 2,000 staff hours in a year, underscoring efficiency gains. Thyme Care achieved profitability ahead of its Series D raise, demonstrating a sustainable business model. Looking forward, the company plans to deepen AI integration to automate documentation, surface real-time insights, and eliminate additional bottlenecks in cancer care. By scaling these capabilities, Thyme Care aims to serve as the backbone for more connected, accountable, and compassionate oncology care nationwide.

Participated · Equity · Sep 2025

Post Acute Analytics (PAA) offers Anna, a proprietary, clinically intelligent platform designed to empower care teams and improve outcomes across the post-acute continuum. The software delivers real-time insights that help providers and payers coordinate care, reduce costs and enhance patient outcomes. PAA plans to use newly raised capital to accelerate Anna’s product roadmap and broaden integrations with healthcare partners. The company also intends to deepen collaborations with both existing provider networks and payer organizations. CEO Saqib Akhter says the fresh investment validates PAA’s technology and market strategy. Financial metrics such as revenue or user counts were not disclosed in the article.

Led · Equity · Jan 2023

Monogram Health is a value-based specialty provider of in-home evidence-based care and benefit management services for patients with polychronic conditions, including chronic kidney disease and end-stage renal disease. Led by CEO Mike Uchrin, the company deploys an in-home care delivery model and a technology-driven array of evidence-based clinical services such as complex case and disease management, utilization management, and medication therapy management. Monogram has numerous value-based partnerships with health plans and risk-bearing providers to care for patients across 34 states and all insurance products. The company raised $375M in growth funding. It intends to use the proceeds to support widespread deployment of its in-home kidney and polychronic care delivery model and to expand its tech-driven clinical services. Monogram Health provides benefit management and at-home care delivery focused exclusively on chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company partners with health plans to deliver an evidence-based renal care model of clinical managed services, including complex case and disease management, utilization management, and medication therapy management. Leveraging a technology and managed-services platform, Monogram's multidisciplinary clinical team of nurses, nephrologists, dieticians, pharmacists, and social workers coordinates with a patient’s entire care network to slow disease progression and manage individualized needs. Monogram currently operates its renal disease clinical managed services across 20 U.S. states and has built a national network of nephrologists that includes hundreds of specialists. In April the company opened an operations center in Arizona to support its growth in Western states. The company intends to use the Series B proceeds to accelerate business expansion. Monogram Health delivers an at-home renal care model and data-driven care management solutions including complex case management, utilization management, and medication therapy management for patients with chronic kidney and end-stage renal disease. The company partners with health plans, physician practices, dialysis providers and clinically integrated health systems to create personalized care plans and a national network of nephrologists. Monogram uses next-generation artificial intelligence and evidence-based criteria to delay disease progression, optimize transitions to dialysis or transplant, and improve outcomes. It currently operates renal disease care management programs across 20 states and reports a readmission rate for its patients that is half the national average. About 90% of Monogram patients are enrolled in Medicare Advantage plans. Monogram is based in Nashville, Tenn., and is privately held by Frist Cressey Ventures and Norwest Venture Partners. Monogram Health provides kidney disease care management through in-home visits and ongoing clinical engagement, using teams of nurses, social workers, nephrologists, and geriatricians. The company partners with health plans and a national network of nephrologists to deliver cost-effective, integrated care and to improve patient outcomes. Monogram uses next-generation artificial intelligence, clinically integrated care delivery, and personalized care planning to delay disease progression and support transitions to dialysis or pre-emptive transplant. It operates renal disease care management programs for thousands of patients across the U.S., including Humana Medicare Advantage and Commercial members in Louisiana and Mississippi. Monogram emphasizes home-based care to reduce hospitalizations and support vulnerable patients during the COVID-19 pandemic. The company is based in Nashville, Tenn.

Participated · Equity · Nov 2022

DispatchHealth is a provider of in‑home medical care that enables patients and their care partners to request services via phone, mobile app, or website. A medical team can arrive within two hours and is equipped to perform high‑acuity medical care in the home. The company operates in the hospital‑at‑home care space. Financially, DispatchHealth recently raised $330M to support its operations and growth. The raise included participation from both existing and new strategic investors, reflecting broad payer and investor interest in home‑based acute care. DispatchHealth delivers on-demand acute medical care and an advanced level of home-based care through mobile medical teams equipped to treat common to complex injuries and illnesses. Its platform offers acute care seven days a week, evenings and holidays, and can be requested via app, online or phone. Advanced Care provides a hospital-at-home substitute with an internal-medicine-trained physician, a physician assistant or nurse practitioner, 24/7 physician coverage with remote monitoring, an emergency call button and daily bedside nursing visits. The company works with payers, providers, health systems, EMS and employer groups to reduce unnecessary ER visits, hospital stays and readmissions. Launched in 2013 and led by CEO Dr. Mark Prather, DispatchHealth plans to expand its in-home platform to a total of 100 markets and scale its Advanced Care service across the United States. Its most recent financing raised the company’s valuation to $1.7 billion. DispatchHealth provides on-demand acute care and advanced medical care for patients of all ages via emergency medicine and internal medicine-trained medical teams. Teams are equipped with the tools needed to treat common to complex injuries and illnesses and typically arrive within two hours after a request via phone, mobile app or website. Examples of care include IV fluids for dehydration, laceration repair, and higher-level interventions for asthma, COPD or congestive heart failure exacerbations. The company works closely with payers, providers and health systems to deliver care in the home and reduce unnecessary emergency room visits, hospital stays and readmissions. Acute care medical teams are available seven days a week, including evenings and holidays, and DispatchHealth is partnered with most major insurance companies. The company says it will use the funds to expand operations and its business reach. DispatchHealth is a Denver-based on-demand health care delivery company that provides in-home care through board-certified medical teams. Led by Dr. Mark Prather, these teams are equipped to treat common to complex injuries and illnesses for patients of all ages and are available during days, evenings, weekends and holidays. Patients request visits via the company's app, online or by phone, and after treatment DispatchHealth sends notes to patients' primary care physicians, senior living communities when applicable, and the patient. The company collects data from hundreds of patients seen each day nationwide to identify care trends and social determinants of health. DispatchHealth works with payers, providers and health systems and is partnered with most major insurance companies. After closing a $33M growth financing, the company plans to expand to additional U.S. locations, broaden treatment capabilities for patients with high medical needs and accelerate investment in its mobile application and logistics platform. DispatchHealth provides on-demand, on-site healthcare services delivered in the home, senior care facility, or office. Founded in 2013 by Dr. Mark Prather and Kevin Riddleberger, the company operates in Denver, Boulder, Colorado Springs and Phoenix. Patients request care via a mobile app, the DispatchHealth website, or by phone and are connected to emergency-trained providers supported by the company's technology infrastructure. Providers are prepared to handle everything from minor illness and injury to more complex clinical cases. The company secured $30.8m in funding and intends to use the capital to scale its technology-enabled healthcare delivery platform. Additional service areas were slated to be announced in the fourth quarter of 2017.

Participated · Series B · Jan 2021

Aspen RxHealth operates a clinical pharmacy services marketplace that intelligently matches pharmacists with patients using social and clinical factors. The company says its community includes more than 5,000 pharmacists, which it describes as the largest in the nation. Aspen positions its model to deliver value to health plans and other risk-bearing providers and to enrich the patient–pharmacist experience. Management plans to scale the marketplace rapidly, pursue broader markets such as specialty pharmacy support and medication reconciliation, and capitalize on increased demand for virtual care. The company framed the offering as a new clinical pharmacy services model developed by pharmacists for pharmacists and led by CEO David Medvedeff. Aspen RxHealth is a Tampa, FL–based developer of an app-based intervention platform that connects pharmacists with patients to deliver clinical services, including medication therapy management (MTM). Its offering includes a mobile app and a full technology platform that ensure quality assurance through pharmacist on-boarding and oversight of all patient interactions. The company intends to use the new funding to accelerate development of its technology platform and to add talent. Aspen RxHealth is led by CEO David Medvedeff. The article does not disclose revenues, users, or other operating metrics. The company focuses on improving clinical service delivery via pharmacist-led interventions through its technology.